EDGAR Filing Documents for 0001193125-16-729297

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-16-729297

Filing Date

2016-10-03

Accepted

2016-10-03 16:04:09

Documents

Period of Report

2016-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	d240722d20f.htm	20-F	1972608
2	EX-4.9	d240722dex49.htm	EX-4.9	7582
3	EX-4.10	d240722dex410.htm	EX-4.10	18767
4	EX-4.17	d240722dex417.htm	EX-4.17	7029
5	EX-4.18	d240722dex418.htm	EX-4.18	722689
6	EX-12.1	d240722dex121.htm	EX-12.1	8475
7	EX-13.1	d240722dex131.htm	EX-13.1	4139
8	GRAPHIC	g240722ex4_10.jpg	GRAPHIC	11264
9	GRAPHIC	g240722ex4_17.jpg	GRAPHIC	10003
10	GRAPHIC	g240722fin_pg02.jpg	GRAPHIC	5982
11	GRAPHIC	g240722sig.jpg	GRAPHIC	4714
	Complete submission text file	0001193125-16-729297.txt		2786850

Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000

Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-35428 | Film No.: 161915802
SIC: 2834 Pharmaceutical Preparations